The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Development of a phase Ib/IIa proof-of-concept study of imalumab (BAX69), a first-in-class anti-macrophage migration inhibitory factor (MIF) antibody, as the 3rd or 4th line treatment in metastatic colorectal cancer (mCRC).
 
Xiaochun Liu
Employment - Baxter
Stock and Other Ownership Interests - Baxter
Travel, Accommodations, Expenses - Baxter
 
Deyaa Rafaat Adib
Employment - Baxter
Stock and Other Ownership Interests - Baxter
Travel, Accommodations, Expenses - Baxter
 
Hila Barak
Employment - Baxter
Stock and Other Ownership Interests - Baxter
Travel, Accommodations, Expenses - Baxter
 
Richard M. Goldberg
Honoraria - Biothera; Lilly; Sanofi
Research Funding - Bayer (Inst); Immunomedics (Inst); Merck (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Merck KGaA; Sanofi
 
Salim Yazji
Employment - Baxter
Stock and Other Ownership Interests - Baxter